Anti-CXCL2 抗体 (ab91511)
Key features and details
- Goat polyclonal to CXCL2
- Suitable for: WB
- Reacts with: Human
- Isotype: IgG
製品の概要
-
製品名
Anti-CXCL2 antibody
CXCL2 一次抗体 製品一覧 -
製品の詳細
Goat polyclonal to CXCL2 -
由来種
Goat -
アプリケーション
適用あり: WBmore details -
種交差性
交差種: Human
交差が予測される動物種: Cynomolgus monkey -
免疫原
Synthetic peptide corresponding to Human CXCL2 aa 94-107 (C terminal). Synthetic peptide:
C-KKIIEKMLKNGKSN
, corresponding to C terminal amino acids 94-107 of Human GRO beta (NP_002080.1).
Sequence:C-KKIIEKMLKNGKSN
-
ポジティブ・コントロール
- Recombinant Human CXCL2 protein (ab84204) can be used as a positive control in WB. Human duodenum lysate
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles. -
バッファー
pH: 7.30
Preservative: 0.02% Sodium azide
Constituents: 0.5% Tris buffered saline, 0.5% BSA -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
ab91511 was purified from goat serum by ammonium sulphate precipitation, followed by antigen affinity chromatography using the immunizing peptide. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab91511の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
Use a concentration of 0.03 - 0.1 µg/ml. Detects a band of approximately 17 kDa (predicted molecular weight: 11 kDa).
1 hour primary incubation is recommended for this product. |
特記事項 |
---|
WB
Use a concentration of 0.03 - 0.1 µg/ml. Detects a band of approximately 17 kDa (predicted molecular weight: 11 kDa). 1 hour primary incubation is recommended for this product. |
ターゲット情報
-
機能
Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity. -
配列類似性
Belongs to the intercrine alpha (chemokine CxC) family. -
翻訳後修飾
The N-terminal processed form GRO-beta(5-73) is produced by proteolytic cleavage after secretion from bone marrow stromal cells. -
細胞内局在
Secreted. - Information by UniProt
-
参照データベース
- Entrez Gene: 2920 Human
- Omim: 139110 Human
- SwissProt: P19875 Human
- Unigene: 75765 Human
-
別名
- C-X-C motif chemokine 2 antibody
- Chemokine (C X C motif) ligand 2 antibody
- Chemokine, CXC motif, ligand 2 antibody
see all
画像
-
Anti-CXCL2 antibody (ab91511) at 0.2 µg/ml + Human duodenum lysate at 35 µg
Developed using the ECL technique.
Predicted band size: 11 kDa
Observed band size: 17 kDa why is the actual band size different from the predicted?
Exposure time: 1 hour -
ab91511 (0.03µg/ml) staining of Daudi lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence
データシートおよび資料
-
Datasheet download
参考文献 (6)
ab91511 は 6 報の論文で使用されています。
- Kim J et al. Single-cell RNA sequencing for the identification of early-stage lung cancer biomarkers from circulating blood. NPJ Genom Med 6:87 (2021). PubMed: 34654834
- Yang J et al. Characteristics of CXCL2 expression in coronary atherosclerosis and negative regulation by microRNA-421. J Int Med Res 48:300060519896150 (2020). PubMed: 32212883
- Wilkinson HN et al. Elevated Local Senescence in Diabetic Wound Healing Is Linked to Pathological Repair via CXCR2. J Invest Dermatol 139:1171-1181.e6 (2019). PubMed: 30684552
- Wan XY et al. Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression. Am J Transl Res 9:155-166 (2017). WB ; Human . PubMed: 28123642
- Buoli Comani G et al. miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation. Genes Nutr 10:482 (2015). PubMed: 26233308
- Magni S et al. miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease. Am J Gastroenterol N/A:N/A (2014). PubMed: 25070052